MitoDys is a drug-discovery platform, working on a novel approach to treating Parkinson's disease.
MitoDys is headed up by founder Steven Zimmer and a world-class board of scientific and clinical advisors led by Dr David Weiner, a clinician scientist who is a noted expert in Parkinson’s disease, along with a network of academic laboratories and partner CROs.
MitoDys hit their target and raised £150,000
The Life Neurological Research Trust, two business angels and SyndicateRoom members.
To fund the initial optimisation and validation of MitoDys’ discovery platform through initial drug prototypes.
Take a look at MitoDys website to find out the latest news: www.mitodys.com